"My research aims to uncover any differences in treatment outcomes among patients with pre-existing type II diabetes at the time of their metastatic melanoma diagnosis. Discovering such differences could prompt further investigation, potentially influencing recommendations regarding dosage and follow-up intervals tailored specifically for this patient population."
This #MRFResearchWednesday, Read about 2024 Medical student grant recipient @SabrinaBruno_ from @PittHealthSci and her research on Outcomes and immune profile of type II diabetic patients on nivolumab. to learn more about Sabrina's research - https://t.co/hIITdc7pkH
Had a great time at #ASCO24 this year! Thank you to my wonderful mentors @AndyKnightMD and @jmkirkwood for the support and guidance with my project. And thank you to everyone who stopped by my poster. #Melanoma#Immunotherapy
YINZ HAVE A NIGHT 🏆 Pittsburgh’s @USLChampionship side @RiverhoundsSC knock off the Columbus Crew 1-0 in the @opencup Their second straight victory over an MLS opponent this competition. If putting fries on a sandwich is wrong, we don’t wanna be right.🖤